Argyle Capital Management Inc. - Q3 2023 holdings

$273 Million is the total value of Argyle Capital Management Inc.'s 122 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 12.0% .

 Value Shares↓ Weighting
MSFT SellMicrosoft Corp$12,665,364
-8.8%
40,112
-1.6%
4.64%
-7.3%
LLY SellLilly Eli & Co$11,914,618
+10.9%
22,182
-3.2%
4.36%
+12.7%
MRK SellMerck & Co Inc$7,385,118
-10.9%
71,735
-0.2%
2.70%
-9.5%
MCK SellMcKesson Corp$7,246,340
+1.4%
16,664
-0.4%
2.65%
+3.0%
DE SellDeere & Company$5,633,529
-7.2%
14,928
-0.4%
2.06%
-5.8%
PAYX SellPaychex Inc$5,627,527
+2.6%
48,795
-0.5%
2.06%
+4.2%
COP SellConocoPhillips$5,442,634
+14.8%
45,431
-0.7%
1.99%
+16.7%
PHM SellPulte Group Inc$5,321,159
-6.9%
71,859
-2.3%
1.95%
-5.4%
CAT SellCaterpillar Inc Del$4,733,820
+10.2%
17,340
-0.7%
1.73%
+12.0%
CSCO SellCisco Sys Inc$4,399,342
+3.7%
81,833
-0.2%
1.61%
+5.4%
ORCL SellOracle Corp$4,289,760
-11.7%
40,500
-0.7%
1.57%
-10.3%
GPC SellGenuine Parts Co$4,055,740
-14.7%
28,091
-0.0%
1.49%
-13.3%
WM SellWaste Management Inc Del$3,048,800
-13.0%
20,000
-1.0%
1.12%
-11.6%
HAL SellHalliburton Co$2,625,413
+21.8%
64,825
-0.8%
0.96%
+23.8%
CMCSA SellComcast Corp Newcl a$2,348,069
+6.4%
52,956
-0.3%
0.86%
+8.2%
CB SellChubb Corp$2,169,444
+7.8%
10,421
-0.3%
0.80%
+9.7%
SO SellSouthern Co$2,166,243
-8.3%
33,471
-0.5%
0.79%
-6.9%
AFL SellAflac Inc$707,635
+4.3%
9,220
-5.1%
0.26%
+5.7%
UGI SellUGI Corp New$477,802
-16.1%
20,774
-1.6%
0.18%
-14.6%
MTB SellM&T Bank Corp$422,722
-21.4%
3,343
-23.0%
0.16%
-20.1%
SellWarner Brothers Discovery Inc$232,882
-14.5%
21,444
-1.2%
0.08%
-13.3%
VTRS SellViatris Inc$124,976
-2.0%
12,675
-0.8%
0.05%0.0%
MDC ExitM D C Hldgs Inc$0-4,320
-100.0%
-0.07%
MGA ExitMagna Intl Inc$0-3,700
-100.0%
-0.08%
LH ExitLaboratory Corp of Amer Hldgs$0-883
-100.0%
-0.08%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-10-26
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Microsoft Corp42Q3 20235.3%
Merck & Co Inc42Q3 20233.2%
Pfizer Inc42Q3 20232.8%
Amgen Inc42Q3 20232.9%
Intel Corp42Q3 20233.1%
Bristol Myers Squibb Co42Q3 20232.9%
Paychex Inc42Q3 20232.3%
Lilly Eli Co42Q3 20234.4%
Verizon Communications42Q3 20232.6%
Johnson & Johnson42Q3 20232.2%

View Argyle Capital Management Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-29
13F-HR2024-02-05
13F-HR2023-10-26
13F-HR2023-07-27
13F-HR2023-04-27
13F-HR2023-02-06
13F-HR2022-10-21
13F-HR2022-07-20
13F-HR2022-04-27
13F-HR2022-01-25

View Argyle Capital Management Inc.'s complete filings history.

Compare quarters

Export Argyle Capital Management Inc.'s holdings